Skip to main content
PMC home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1990 Dec;80(12):1507–1509. doi: 10.2105/ajph.80.12.1507

HIV seroprevalence among male IVDUs in Houston, Texas.

M L Williams
PMCID: PMC1405124  PMID: 2135633

Abstract

HIV seroprevalence was 8.4 percent in a sample of 921 heterosexual male intravenous drug users in Houston, Texas who were not in drug treatment at the time of the study. Males who were Black, injected drugs daily, or had a history of syphilis had greater odds of being HIV positive than participants without those characteristics.

Full text

PDF
1508

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chaisson R. E., Bacchetti P., Osmond D., Brodie B., Sande M. A., Moss A. R. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA. 1989 Jan 27;261(4):561–565. [PubMed] [Google Scholar]
  2. Curran J. W., Jaffe H. W., Hardy A. M., Morgan W. M., Selik R. M., Dondero T. J. Epidemiology of HIV infection and AIDS in the United States. Science. 1988 Feb 5;239(4840):610–616. doi: 10.1126/science.3340847. [DOI] [PubMed] [Google Scholar]
  3. Des Jarlais D. C., Friedman S. R. HIV infection among persons who inject illicit drugs: problems and prospects. J Acquir Immune Defic Syndr. 1988;1(3):267–273. [PubMed] [Google Scholar]
  4. Des Jarlais D. C., Wish E., Friedman S. R., Stoneburner R., Yancovitz S. R., Mildvan D., el-Sadr W., Brady E., Cuadrado M. Intravenous drug use and the heterosexual transmission of the human immunodeficiency virus. Current trends in New York City. N Y State J Med. 1987 May;87(5):283–286. [PubMed] [Google Scholar]
  5. Friedman S. R., Des Jarlais D. C., Neaigus A., Abdul-Quader A., Sotheran J. L., Sufian M., Tross S., Goldsmith D. AIDS and the new drug injector. Nature. 1989 Jun 1;339(6223):333–334. doi: 10.1038/339333a0. [DOI] [PubMed] [Google Scholar]
  6. Hahn R. A., Onorato I. M., Jones T. S., Dougherty J. Prevalence of HIV infection among intravenous drug users in the United States. JAMA. 1989 May 12;261(18):2677–2684. [PubMed] [Google Scholar]
  7. Lange W. R., Snyder F. R., Lozovsky D., Kaistha V., Kaczaniuk M. A., Jaffe J. H. Geographic distribution of human immunodeficiency virus markers in parenteral drug abusers. Am J Public Health. 1988 Apr;78(4):443–446. doi: 10.2105/ajph.78.4.443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Newmeyer J. A., Feldman H. W., Biernacki P., Watters J. K. Preventing AIDS contagion among intravenous drug users. Med Anthropol. 1989 Mar;10(2-3):167–175. doi: 10.1080/01459740.1989.9965962. [DOI] [PubMed] [Google Scholar]
  9. Sasse H., Salmaso S., Conti S. Risk behaviors for HIV-1 infection in Italian drug users: report from a multicenter study. First Drug User Multicenter Study Group. J Acquir Immune Defic Syndr. 1989;2(5):486–496. [PubMed] [Google Scholar]
  10. Selik R. M., Castro K. G., Pappaioanou M., Buehler J. W. Birthplace and the risk of AIDS among Hispanics in the United States. Am J Public Health. 1989 Jul;79(7):836–839. doi: 10.2105/ajph.79.7.836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Selik R. M., Castro K. G., Pappaioanou M. Racial/ethnic differences in the risk of AIDS in the United States. Am J Public Health. 1988 Dec;78(12):1539–1545. doi: 10.2105/ajph.78.12.1539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Sudman S., Sirken M. G., Cowan C. D. Sampling rare and elusive populations. Science. 1988 May 20;240(4855):991–996. doi: 10.1126/science.240.4855.991. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES